Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3)

Journal of Biological Chemistry

Volumn 289, Issue 45, 2014, Pages 31373-31381

  Qi, Jin ^a   Huo, Lei ^b   Zhu, Yiwei Tony ^c   Zhu, Yi Jun ^c  

^a Maternal and Child Health Care Hospital of Shaanxi Province   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; DISEASES; PROTEINS;

BINDING PROTEINS; BREAST CANCER; BREAST CANCER CELLS; ESTROGEN RECEPTOR; GENE AMPLIFICATION; MAMMARY EPITHELIAL CELLS; TRANSCRIPTIONAL ACTIVITY; TRIMETHYLATION;

TRANSCRIPTION;

ABSENT SMALL OR HOMEOTIC 2 LIKE PROTEIN; ESTROGEN RECEPTOR ALPHA; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; ASH2L PROTEIN, HUMAN; ASH2L PROTEIN, MOUSE; DNA BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA, HUMAN; HISTONE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ESTROGEN RECEPTOR ALPHA GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BINDING SITE; BREAST TUMOR; CELL LINE; ENHANCER REGION; FEMALE; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TWO HYBRID SYSTEM;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; ESTROGEN RECEPTOR ALPHA; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HISTONES; HUMANS; MICE; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84909606594     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.579839     Document Type: Article

References (63)

1. Hennighausen, L., and Robinson, G. W. (1998) Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12, 449-455
2. Neville, M. C., McFadden, T. B., and Forsyth, I. (2002) Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia 7, 49-66
3. Brisken, C. (2002) Hormonal control of alveolar development and its implications for breast carcinogenesis. J. Mammary Gland Biol. Neoplasia 7, 39-48
4. Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Hewlett, J., Davies, M. P., Sibson, D. R., and Sloane, J. P. (1999) Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155, 1811-1815
5. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
6. Mosselman, S., Polman, J., and Dijkema, R. (1996) ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53
7. Korach, K. S., Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J., Kimbro, K. S., Eddy, E. M., Migliaccio, S., Snedeker, S. M., Lubahn, D. B., Schomberg, D. W., and Smith, E. P. (1996) Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51, 159-186; discussion 186-158
8. Porter, W., Wang, F., Wang, W., Duan, R., and Safe, S. (1996) Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol. Endocrinol. 10, 1371-1378
9. Webb, P., Lopez, G. N., Uht, R. M., and Kushner, P. J. (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9, 443-456
10. Early Breast Cancer Trialists' Collaborative Group. (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339, 71-85
11. Nass, S. J., and Davidson, N. E. (1999) The biology of breast cancer. Hematol. Oncol. Clin. North Am. 13, 311-332
12. Kos, M., Reid, G., Denger, S., and Gannon, F. (2001) Minireview: genomic organization of the human ERα gene promoter region. Mol. Endocrinol. 15, 2057-2063
13. McPherson, L. A., Baichwal, V. R., and Weigel, R. J. (1997) Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. U.S.A. 94, 4342-4347
14. Guo, S., and Sonenshein, G. E. (2004) Forkhead box transcription factor FOXO3a regulates estrogen receptor α expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 24, 8681-8690
15. Madureira, P. A., Varshochi, R., Constantinidou, D., Francis, R. E., Coombes, R. C., Yao, K. M., and Lam, E. W. (2006) The Forkhead box M1 protein regulates the transcription of the estrogen receptor α in breast cancer cells. J. Biol. Chem. 281, 25167-25176
16. Eeckhoute, J., Keeton, E. K., Lupien, M., Krum, S. A., Carroll, J. S., and Brown, M. (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor α expression in breast cancer. Cancer Res. 67, 6477-6483
17. Park, Y. Y., Kim, K., Kim, S. B., Hennessy, B. T., Kim, S. M., Park, E. S., Lim, J. Y., Li, J., Lu, Y., Gonzalez-Angulo, A. M., Jeong, W., Mills, G. B., Safe, S., and Lee, J. S. (2012) Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol. Med. 4, 52-67
18. Pinzone, J. J., Stevenson, H., Strobl, J. S., and Berg, P. E. (2004) Molecular and cellular determinants of estrogen receptor α expression. Mol. Cell. Biol. 24, 4605-4612
19. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., and O'Malley, B. W. (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 1858-1862
20. Clarke, R. B., Anderson, E., and Howell, A. (2004) Steroid receptors in human breast cancer. Trends Endocrinol. Metab. 15, 316-323
21. Martin, C., and Zhang, Y. (2005) The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 6, 838-849
22. Shilatifard, A. (2008) Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 20, 341-348
23. Tenney, K., and Shilatifard, A. (2005) A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: linking leukemogensis to covalent modifications of chromatin. J. Cell. Biochem. 95, 429-436
24. Ansari, K. I., and Mandal, S. S. (2010) Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J. 277, 1790-1804
25. Cho, Y. W., Hong, T., Hong, S., Guo, H., Yu, H., Kim, D., Guszczynski, T., Dressler, G. R., Copeland, T. D., Kalkum, M., and Ge, K. (2007) PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282, 20395-20406
26. Issaeva, I., Zonis, Y., Rozovskaia, T., Orlovsky, K., Croce, C. M., Nakamura, T., Mazo, A., Eisenbach, L., and Canaani, E. (2007) Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 27, 1889-1903
27. Miller, T., Krogan, N. J., Dover, J., Erdjument-Bromage, H., Tempst, P., Johnston, M., Greenblatt, J. F., and Shilatifard, A. (2001) COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl. Acad. Sci. U.S.A. 98, 12902-12907
28. Goo, Y.H., Sohn, Y. C., Kim, D. H., Kim, S. W., Kang, M. J., Jung, D. J., Kwak, E., Barlev, N. A., Berger, S. L., Chow, V. T., Roeder, R. G., Azorsa, D. O., Meltzer, P. S., Suh, P. G., Song, E. J., Lee, K. J., Lee, Y. C., and Lee, J. W. (2003) Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol. 23, 140-149
29. Agger, K., Cloos, P. A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A. E., and Helin, K. (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731-734
30. Lan, F., Bayliss, P. E., Rinn, J. L., Whetstine, J. R., Wang, J. K., Chen, S., Iwase, S., Alpatov, R., Issaeva, I., Canaani, E., Roberts, T. M., Chang, H. Y., and Shi, Y. (2007) A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449, 689-694
31. Zhu, Y., Kan, L., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S., and Reddy, J. K. (2000) Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J. Biol. Chem. 275, 13510-13516
32. Mahajan, M. A., and Samuels, H. H. (2000) A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol. Cell. Biol. 20, 5048-5063
33. Caira, F., Antonson, P., Pelto-Huikko, M., Treuter, E., and Gustafsson, J. A. (2000) Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J. Biol. Chem. 275, 5308-5317
34. Lee, S. K., Anzick, S. L., Choi, J. E., Bubendorf, L., Guan, X. Y., Jung, Y. K., Kallioniemi, O. P., Kononen, J., Trent, J. M., Azorsa, D., Jhun, B. H., Cheong, J. H., Lee, Y. C., Meltzer, P. S., and Lee, J. W. (1999) A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. 274, 34283-34293
35. Garapaty, S., Xu, C. F., Trojer, P., Mahajan, M. A., Neubert, T. A., and Samuels, H. H. (2009) Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation. J. Biol. Chem. 284, 7542-7552
36. Patel, A., Vought, V. E., Dharmarajan, V., and Cosgrove, M. S. (2011) A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex. J. Biol. Chem. 286, 3359-3369
37. Cao, F., Chen, Y., Cierpicki, T., Liu, Y., Basrur, V., Lei, M., and Dou, Y. (2010) An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS One 5, e14102
38. Chen, Y., Wan, B., Wang, K. C., Cao, F., Yang, Y., Protacio, A., Dou, Y., Chang, H. Y., and Lei, M. (2011) Crystal structure of the N-terminal region of human Ash2L shows a winged-helix motif involved in DNA binding. EMBO Rep. 12, 797-803
39. Sarvan, S., Avdic, V., Tremblay, V., Chaturvedi, C. P., Zhang, P., Lanouette, S., Blais, A., Brunzelle, J. S., Brand, M., and Couture, J. F. (2011) Crystal structure of the trithorax group protein ASH2L reveals a forkhead-like DNA binding domain. Nat. Struct. Mol. Biol. 18, 857-859
40. Lüscher-Firzlaff, J., Gawlista, I., Vervoorts, J., Kapelle, K., Braunschweig, T., Walsemann, G., Rodgarkia-Schamberger, C., Schuchlautz, H., Dreschers, S., Kremmer, E., Lilischkis, R., Cerni, C., Wellmann, A., and Lüscher, B. (2008) The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 68, 749-758
41. Stoller, J. Z., Huang, L., Tan, C. C., Huang, F., Zhou, D. D., Yang, J., Gelb, B. D., and Epstein, J. A. (2010) Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp. Biol. Med. 235, 569-576
42. Rampalli, S., Li, L., Mak, E., Ge, K., Brand, M., Tapscott, S. J., and Dilworth, F. J. (2007) p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat. Struct. Mol. Biol. 14, 1150-1156
43. Tan, C. C., Sindhu, K. V., Li, S., Nishio, H., Stoller, J. Z., Oishi, K., Puttreddy, S., Lee, T. J., Epstein, J. A., Walsh, M. J., and Gelb, B. D. (2008) Transcription factor Ap2δ associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription. Proc. Natl. Acad. Sci. U.S.A. 105, 7472-7477
44. Yang, J., Richards, J., Guzman, R., Imagawa, W., and Nandi, S. (1980) Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels. Proc. Natl. Acad. Sci. U.S.A. 77, 2088-2092
45. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852
46. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527
47. Gelsi-Boyer, V., Orsetti, B., Cervera, N., Finetti, P., Sircoulomb, F., Rougé, C., Lasorsa, L., Letessier, A., Ginestier, C., Monville, F., Esteyriès, S., Adélaïde, J., Esterni, B., Henry, C., Ethier, S. P., Bibeau, F., Mozziconacci, M. J., Charafe-Jauffret, E., Jacquemier, J., Bertucci, F., Birnbaum, D., Theillet, C., and Chaffanet, M. (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol. Cancer Res. 3, 655-667
48. Yang, Z. Q., Streicher, K. L., Ray, M. E., Abrams, J., and Ethier, S. P. (2006) Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 66, 11632-11643
49. Mo, R., Rao, S. M., and Zhu, Y. J. (2006) Identification of the MLL2 complex as a coactivator for estrogen receptor α. J. Biol. Chem. 281, 15714-15720
50. Sircoulomb, F., Nicolas, N., Ferrari, A., Finetti, P., Bekhouche, I., Rousselet, E., Lonigro, A., Adélaïde, J., Baudelet, E., Esteyriès, S., Wicinski, J., Audebert, S., Charafe-Jauffret, E., Jacquemier, J., Lopez, M., Borg, J. P., Sotiriou, C., Popovici, C., Bertucci, F., Birnbaum, D., Chaffanet, M., and Ginestier, C. (2011) ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Mol. Med. 3, 153-166
51. Bresnick, E. H., Martowicz, M. L., Pal, S., and Johnson, K. D. (2005) Developmental control via GATA factor interplay at chromatin domains. J. Cell. Physiol. 205, 1-9
52. Viger, R. S., Guittot, S. M., Anttonen, M., Wilson, D. B., and Heikinheimo, M. (2008) Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol. Endocrinol. 22, 781-798
53. Hosoya, T., Maillard, I., and Engel, J. D. (2010) From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol. Rev. 238, 110-125
54. Kouros-Mehr, H., Kim, J. W., Bechis, S. K., and Werb, Z. (2008) GATA-3 and the regulation of the mammary luminal cell fate. Curr. Opin. Cell Biol. 20, 164-170
55. Asselin-Labat, M. L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J., Lindeman, G. J., and Visvader, J. E. (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell. Biol. 9, 201-209
56. Fang, S. H., Chen, Y., and Weigel, R. J. (2009) GATA-3 as a marker of hormone response in breast cancer. J. Surg. Res. 157, 290-295
57. Lacroix, M., and Leclercq, G. (2004) About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol. Cell. Endocrinol. 219, 1-7
58. Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerød, A., Ka˚resen, R., Oh, D. S., Dressler, L. G., Lønning, P. E., Strausberg, R. L., Chanock, S., Børresen-Dale, A. L., and Perou, C. M. (2004) Mutation of GATA3 in human breast tumors. Oncogene 23, 7669-7678
59. Arnold, J. M., Choong, D. Y., Thompson, E. R., kConFab, Waddell, N., Lindeman, G. J., Visvader, J. E., Campbell, I. G., and Chenevix-Trench, G. (2010) Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors. Breast Cancer Res. Treat. 119, 491-496
60. Ray, M. E., Yang, Z. Q., Albertson, D., Kleer, C. G., Washburn, J. G., Macoska, J. A., and Ethier, S. P. (2004) Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 64, 40-47
61. Garcia, M. J., Pole, J. C., Chin, S. F., Teschendorff, A., Naderi, A., Ozdag, H., Vias, M., Kranjac, T., Subkhankulova, T., Paish, C., Ellis, I., Brenton, J. D., Edwards, P. A., and Caldas, C. (2005) A1Mbminimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24, 5235-5245
62. Adélaïde, J., Chaffanet, M., Imbert, A., Allione, F., Geneix, J., Popovici, C., van Alewijk, D., Trapman, J., Zeillinger, R., Børresen-Dale, A. L., Lidereau, R., Birnbaum, D., and Pébusque, M. J. (1998) Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22, 186-199
63. Holland, D. G., Burleigh, A., Git, A., Goldgraben, M. A., Perez-Mancera, P. A., Chin, S. F., Hurtado, A., Bruna, A., Ali, H. R., Greenwood, W., Dunning, M. J., Samarajiwa, S., Menon, S., Rueda, O. M., Lynch, A. G., McKinney, S., Ellis, I. O., Eaves, C. J., Carroll, J. S., Curtis, C., Aparicio, S., and Caldas, C. (2011) ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol. Med. 3, 167-180